PPA
PLXP

Parametric Portfolio Associates’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Parametric Portfolio Associates’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-79,541
Closed -$1.53M – 3721
2021
Q3 		$1.53M Buy
+79,541
New +$1.39M ﹤0.01% 2583

Other funds holding PLXP

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

Parametric Portfolio Associates's PLXP Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 79,541 shares — an estimated $1.53M sold.

Parametric Portfolio Associates first reported a position in PLXP in Q3 2021 and held it in 1 quarter. The position peaked at $1.53M in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 79,541 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $1.53M.
  • Parametric Portfolio Associates first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's PLx Pharma Inc. Common Stock position peaked at $1.53M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.